Latest Schedule 13D activist filings

Futurewave Acquisition Corp's Schedule 13D filing reveals Futurewave Capital Solutions Ltd and Daniel M. McCabe collectively hold 30.8% of ordinary shares, acquired through founder shares and private units.

Uber Technologies, Inc. has sold a substantial portion of its stake in Aurora Innovation, Inc., reducing its beneficial ownership to 10.9% through a block sale.

Uber Technologies, Inc. has sold a substantial portion of its stake in Aurora Innovation, Inc., reducing its beneficial ownership to 10.9% through a block sale.

Pelican II Capital Solutions Ltd, the sponsor of Pelican Acquisition II Corp, has disclosed a beneficial ownership of 26.36% of the issuer's ordinary shares following its initial public offering.

OceanLight Capital Sponsor Ltd. has filed a Schedule 13D detailing its beneficial ownership of 33.53% of OceanLight Acquisition Corp's ordinary shares following the company's IPO.

Pictet Asset Management SA has filed a Schedule 13D, disclosing beneficial ownership of 4.93% of Fortune Brands Innovations, Inc. common stock, and outlines its active engagement strategy.

Better Home & Finance Holding Co. reports that Vishal Garg's attempt to remove directors failed, leading to a lawsuit filed by the company against Garg for alleged violations of securities laws.

Paine Schwartz Food Chain Fund V GP, Ltd. has increased its beneficial ownership in Suja Life, Inc. to 62.77% through open market purchases, signaling continued investment and potential strategic involvement.

JBS N.V. has submitted a non-binding proposal to acquire the remaining outstanding shares of Pilgrims Pride Corporation (PPC) not already owned by JBS, at a fixed exchange ratio.

Maximilian Martin has increased beneficial ownership in Enhanced Group Inc. to 9.6% through a private placement involving shares and warrants, with registration rights secured.

Digital Currency Group and Fortitude Mining Holdings have jointly filed a Schedule 13D, detailing their acquisition of a 9.4% stake in HeartSciences Inc. as part of a merger agreement.

Skye Bioscience announces a definitive agreement to acquire Redx Pharma Limited, alongside a $72.9 million concurrent financing and the introduction of contingent value rights.

Alco Investment Company has filed an amendment to its Schedule 13D, reporting a decrease in its beneficial ownership of Banzai International, Inc. Class A Common Stock to 0.4% due to dilutive equity issuances.

Catalyst4, Inc. has amended its Schedule 13D filing to disclose its increased beneficial ownership in MapLight Therapeutics, Inc. following a PIPE offering.

Katapult Holdings, Inc. files a Schedule 13D detailing beneficial ownership changes and lock-up agreements following the completion of its mergers with CCF Holdings LLC and Aaron's Intermediate Holdco, Inc.

TPG Inc. files an amendment to its Schedule 13D, detailing adjustments in beneficial ownership by TPG GP A, LLC, James G. Coulter, and Jon Winkelried following a Q3 2026 Exchange.

Saba Capital Management, L.P. has reported a significant reduction in its beneficial ownership of NYLI CBRE Global Infrastructure Megatrends Term Fund common shares, selling over 2.9 million shares.

A Schedule 13D filing reveals that AE Equity Limited, wholly owned by SunScout Holding Ltd CEO Friedrich Edwin Cywinski, holds 6,600,000 Class A Ordinary Shares, representing 27.5% of the voting power of Class A shares.

Tatsuya Akimoto has disclosed beneficial ownership of 135,454,900 shares, representing 27.81% of Advasa Holdings, Inc., following a share exchange agreement.

SunScout Holding Ltd reports a change in beneficial ownership for Marc Cywinski and Solerin Equity Limited, detailing shareholdings and a lock-up agreement.

Asamitsu Kosugi has filed a Schedule 13D, disclosing beneficial ownership of 232,638,232 shares, representing 47.76% of Advasa Holdings, Inc.

Ensysce Biosciences, Inc. details a common stock purchase warrant issuance and a Schedule 13D filing by major shareholder Bob Gene Gower, outlining share ownership and voting agreements.

Yinan Ren files an amendment to Schedule 13D for YY Group Holding Limited, correcting the percentage of Class A Ordinary Shares beneficially owned.

Fresenius Medical Care Holdings, Inc. and Fresenius Medical Care AG have reduced their stake in Humacyte, Inc. to below 5% following a series of share sales.

Baihui Partners L.P. has amended its Schedule 13D filing to reflect a change in its beneficial ownership percentage of KE Holdings Inc. due to a reduction in the total number of issued ordinary shares.

Jeffrey Sharpe has increased his beneficial ownership in Conexeu Sciences Inc. to 5.4% following the vesting of performance warrants tied to market capitalization milestones.

An amended Schedule 13D filing reveals Propitious Global Holdings Limited, along with related entities, continues to hold a significant stake in KE Holdings Inc., with no new transactions reported in the last 60 days.

GoHealth, Inc. common stock has been cancelled as part of a prepackaged Chapter 11 plan of reorganization, resulting in no equity recovery for former shareholders.

Several Oaktree-affiliated entities have filed an amendment to their Schedule 13D, reporting an updated beneficial ownership of Battalion Oil Corporation's common stock.

Several Oaktree-affiliated entities have filed an amendment to their Schedule 13D, reporting an updated beneficial ownership of Battalion Oil Corporation's common stock.